Chemotherapy-induced metastasis: molecular mechanisms and clinical therapies

被引:19
|
作者
Su, Jin-xuan [1 ,2 ]
Li, Si-jia [1 ,2 ]
Zhou, Xiao-feng [1 ,2 ]
Zhang, Zhi-jing [1 ,2 ]
Yan, Yu [3 ]
Liu, Song-lin [4 ]
Qi, Qi [1 ,2 ]
机构
[1] Jinan Univ, Sch Med, Dept Pharmacol, State Key Lab Bioact Mol & Druggabil Assessment, Guangzhou 510632, Peoples R China
[2] Jinan Univ, Sch Med, Dept Pharmacol, MOE Key Lab Tumor Mol Biol, Guangzhou 510632, Peoples R China
[3] Jinan Univ, Funct Expt Teaching Ctr, Sch Med, Guangzhou 510632, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Peoples R China
基金
中国国家自然科学基金;
关键词
anti-cancer drugs; chemotherapy; metastasis; combination therapy; BREAST-CANCER CELLS; FACTOR-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; LUNG-CANCER; TGF-BETA; PANCREATIC-CANCER; TUMOR-CELLS; TAMOXIFEN RESISTANCE; LIVER METASTASIS; DOUBLE-BLIND;
D O I
10.1038/s41401-023-01093-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chemotherapy, the most widely accepted treatment for malignant tumors, is dependent on cell death induced by various drugs including antimetabolites, alkylating agents, mitotic spindle inhibitors, antitumor antibiotics, and hormonal anticancer drugs. In addition to causing side effects due to non-selective cytotoxicity, chemotherapeutic drugs can initiate and promote metastasis, which greatly reduces their clinical efficacy. The knowledge of how they induce metastasis is essential for developing strategies that improve the outcomes of chemotherapy. Herein, we summarize the recent findings on chemotherapy-induced metastasis and discuss the underlying mechanisms including tumor-initiating cell expansion, the epithelial-mesenchymal transition, extracellular vesicle involvement, and tumor microenvironment alterations. In addition, the use of combination treatments to overcome chemotherapy-induced metastasis is also elaborated.
引用
收藏
页码:1725 / 1736
页数:12
相关论文
共 50 条
  • [21] Experimental and investigational therapies for chemotherapy-induced anemia
    Testa, Ugo
    Castelli, Germana
    Elvira, Pelosi
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (11) : 1433 - 1445
  • [22] Mechanisms of chemotherapy-induced behavioral toxicities
    Vichaya, Elisabeth G.
    Chiu, Gabriel S.
    Krukowski, Karen
    Lacourt, Tamara E.
    Kavelaars, Annemieke
    Dantzer, Robert
    Heijnen, Cobi J.
    Walker, Adam K.
    FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [23] The role of cell mechanics in chemotherapy-induced metastasis
    Virdi, Sukhman
    Herrero, Nicholas
    Bryant, Israel
    Jordan, Destiny
    Abraham, Ashley
    Khaparde, Gargee
    Jacob, Megha
    Nwakama, Chisom
    Ekpenyong, Andrew E.
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 266A - 266A
  • [24] Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
    Zajaczkowska, Renata
    Kocot-Kepska, Magdalena
    Leppert, Wojciech
    Wrzosek, Anna
    Mika, Joanna
    Wordliczek, Jerzy
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)
  • [25] Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies
    Allyson J. Ocean
    Linda T. Vahdat
    Supportive Care in Cancer, 2004, 12 : 619 - 625
  • [26] Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies
    Ocean, AJ
    Vahdat, LT
    SUPPORTIVE CARE IN CANCER, 2004, 12 (09) : 619 - 625
  • [27] Candidate mechanisms for chemotherapy-induced cognitive changes
    Tim A. Ahles
    Andrew J. Saykin
    Nature Reviews Cancer, 2007, 7 : 192 - 201
  • [28] Candidate mechanisms for chemotherapy-induced cognitive changes
    Ahles, Tim A.
    Saykin, Andrew J.
    NATURE REVIEWS CANCER, 2007, 7 (03) : 192 - 201
  • [29] MECHANISMS AND GENETICS OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
    Staff, Nathan P.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2025, 30 (01)
  • [30] Mechanisms and vulnerabilities for chemotherapy-induced cognitive decline
    Ahles, TA
    Saykin, AJ
    PSYCHO-ONCOLOGY, 2003, 12 (04) : S131 - S131